Updated on 4 August 2026
Revolutionary Youngflex Preventive Therapy for chronic pains
Founder & CEO at Youngflex Manufacturing Inc.
Canada
About
Revolutionary Natural Youngflex Preventive Therapy has three following aspects:(1)brand-new software - established "Root Causes" of each chronic pain symptom that X-rays, CT or MRI cannot systematically locate;(2) brand-new hardware - invented a topical herbal remedy consisting a number of world standard essential oils to remove muscle and soft tissue pain from the Root causes so as to allow smooth blood circulation, thereby nutrients such as calcium, collagen etc. can smoothly flow into weak joints/spine making them strong and allow muscles and soft tissues to regain tenacity and flexibility in order to avoid damages to joints and spine.
Project Location
- Canada
Project Website
https://www.youngflex.com
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Partner Identification
Government approval on
15/11/2004
Tender submission by
15/02/1995
Contract awarded on
15/03/2023
Target completion by
15/07/2026
Main Project Sector
- Technology
Technology
- Bio-Tech
Other Sector(s)
Youngflex Preventive Therapy is brand-new alternative therapy, which takes many years of research and market testing
Total Project Value
- 5,000,001 to 7,500,000 USD
Investment Capital Required
- 500,001 to 1,000,000 USD
Interested Format of Cooperation
- Minority Shareholdings
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Total amount raised (USD)
4.5 million
Return on Investment
53%
Main Service(s) Required
- Professional Services
Professional Services
- Consultancy
- Legal Advisory
Attached files
Organisation
Similar opportunities
Project
AI-Enabled Quantitative MRI Platform for Early Disease Assessment
- No
- No
- Equity
- Technology
- Private Project
- Convertible Loan
- Equity (private)
- Financial Services
- Open for Negotiation
- Direct Equity Investment
- 1,000,001 to 2,500,000 USD
- 7,500,001 to 10,000,000 USD
- Investment / Financing Discussion
Carmen Ng
CEO at CAPRiser Group
Canada
Project
AI Driven Quant Analysis Report for HK Stock Market
- No
- No
- Equity
- Fin-Tech
- Insurance
- Technology
- Securities
- Hedge Funds
- Private Project
- Fund Management
- Financial Services
- Investment Banking
- Financial Advisory
- Venture Capital (VC)
- Minority Shareholdings
- Requisition of Service
- 500,001 to 1,000,000 USD
- 500,001 to 1,000,000 USD
- Direct Equity Investment
- Institutional Investment
- Private Equity & Venture Capital
- Investment / Financing Discussion
- Risk Management (Financial Services)
Larry Li
CEO at 中环懂王
China (Hong Kong)
Project
Project for Potential Osteoarthritis Global Player
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Bootstrapping
- Private Project
- Financial Services
- Open for negotiation
- Open for Negotiation
- 50,000,001 USD or above
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Seungtaek NA
CEO at StarryBio
South Korea